HealthEquity, Inc.
General ticker "HQY" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $8.4B (TTM average)
HealthEquity, Inc. follows the US Stock Market performance with the rate: 2.5%.
Estimated limits based on current volatility of 2.4%: low 81.63$, high 85.64$
Factors to consider:
- Total employees count: 3120 (-0.2%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Tax benefits loss, Market competition, Cybersecurity threats, Third-party risks, Service provider risks
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-01-31 to 2028-01-31
- 2026-01-31 to 2027-01-31 estimated range: [70.41$, 105.17$]
- 2027-01-31 to 2028-01-31 estimated range: [71.09$, 106.38$]
Financial Metrics affecting the HQY estimates:
- Negative: with PPE of 21.1 at the end of fiscal year the price was high
- Positive: Operating profit margin, % of 24.55 > 18.52
- Positive: 0.07 < Operating cash flow per share per price, % of 6.28
- Positive: -4.45 < Investing cash flow per share per price, % of -0.65
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: 1.88 < Return on assets ratio (scaled to [-100,100]) of 5.90
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: Industry operating profit margin (median), % of -7.54 <= 3.02
Short-term HQY quotes
Long-term HQY plot with estimates
Financial data
| YTD | 2024-01-31 | 2025-01-31 | 2026-01-31 |
|---|---|---|---|
| Operating Revenue | $999.59MM | $1,199.77MM | $1,313.43MM |
| Operating Expenses | $881.89MM | $1,037.44MM | $990.97MM |
| Operating Income | $117.70MM | $162.33MM | $322.46MM |
| Non-Operating Income | $-42.66MM | $-46.30MM | $-45.02MM |
| Interest Expense | $55.45MM | $60.63MM | $57.13MM |
| R&D Expense | $218.81MM | $239.51MM | $262.51MM |
| Income(Loss) | $75.04MM | $116.03MM | $277.43MM |
| Taxes | $19.33MM | $19.33MM | $62.23MM |
| Profit(Loss)* | $55.71MM | $96.70MM | $215.20MM |
| Stockholders Equity | $2,035.02MM | $2,114.91MM | $2,107.20MM |
| Assets | $3,163.79MM | $3,448.55MM | $3,432.04MM |
| Operating Cash Flow | $242.83MM | $339.86MM | $457.09MM |
| Capital expenditure | $46.07MM | $2.08MM | $1.97MM |
| Investing Cash Flow | $-46.07MM | $-505.45MM | $-47.14MM |
| Financing Cash Flow | $-47.04MM | $57.57MM | $-386.98MM |
| Earnings Per Share** | $0.65 | $1.11 | $2.50 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.